BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35476744)

  • 21. The results of a major demonstration and evaluation program undertaken by HCFA in 1989: the Medicare Alzheimer's Disease Demonstration and Evaluation Program (MADDE).
    Williams TF
    Health Serv Res; 1999 Aug; 34(3):641-3. PubMed ID: 10465643
    [No Abstract]   [Full Text] [Related]  

  • 22. Misclassification of Hospital Performance Under the Hospital Readmissions Reduction Program: Implications for Value-Based Programs.
    Shen C; Wadhera RK; Yeh RW
    JAMA Cardiol; 2021 Mar; 6(3):332-335. PubMed ID: 33052371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clinical and Financial Consequences of the Centers for Medicare and Medicaid Services' Two-Midnight Rule in Total Joint Arthroplasty.
    Schwartz AJ; Clarke HD; Sassoon A; Neville MR; Etzioni DA
    J Arthroplasty; 2020 Jan; 35(1):1-6.e1. PubMed ID: 31591011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 Timeline: Centers for Medicare and Medicaid Services (CMS) Changes and Primary Care Support Were Not Enough to Prevent Practice Losses.
    Gausvik C; Jabbarpour Y
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S7-S9. PubMed ID: 33622808
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving The Accuracy Of Hospital Quality Ratings By Focusing On The Association Between Volume And Outcome.
    Glance LG; Thirukumaran CP; Li Y; Gao S; Dick AW
    Health Aff (Millwood); 2020 May; 39(5):862-870. PubMed ID: 32364861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?
    Kimura T; Takamatsu J; Araki N; Goto M; Kondo A; Miyakawa T; Horiuchi S
    Neuroreport; 1995 Apr; 6(6):866-8. PubMed ID: 7612872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The problematic lag between FDA approval of medical devices and CMS coverage.
    Knight BP; Deering TF; Gold MR; Mittal S; Singh JP
    J Cardiovasc Electrophysiol; 2021 Jul; 32(7):1801-1802. PubMed ID: 34056780
    [No Abstract]   [Full Text] [Related]  

  • 28. An Evolving Hospital Quality Star Rating System From CMS: Aligning the Stars.
    Bilimoria KY; Barnard C
    JAMA; 2021 Jun; 325(21):2151-2152. PubMed ID: 33999111
    [No Abstract]   [Full Text] [Related]  

  • 29. Data Characterization of Medicaid: Legacy and New Data Formats in the CMS Virtual Research Data Center.
    Williams N; Mayer CS; Huser V
    AMIA Jt Summits Transl Sci Proc; 2021; 2021():644-652. PubMed ID: 34457180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of the Autopsy Requirement by CMS.
    Rueckert J
    N Engl J Med; 2020 Feb; 382(7):683-684. PubMed ID: 32053309
    [No Abstract]   [Full Text] [Related]  

  • 31. CMS issues new instructions on PET coverage.
    J Nucl Med; 2014 Apr; 55(4):9N-10N. PubMed ID: 24692282
    [No Abstract]   [Full Text] [Related]  

  • 32. Using Policy to Improve Access to Care for Persons With Alzheimer's Disease.
    Skipper AW; Zanetos J
    J Gerontol Nurs; 2019 Dec; 45(12):7-11. PubMed ID: 31755537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target Prices Influence Hospital Participation And Shared Savings In Medicare Bundled Payment Program.
    Berlin NL; Gulseren B; Nuliyalu U; Ryan AM
    Health Aff (Millwood); 2020 Sep; 39(9):1479-1485. PubMed ID: 32897775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare for people with Alzheimer's disease.
    Fried L
    Issue Brief Cent Medicare Educ; 2004; 5(8):1-6. PubMed ID: 15580711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Centers for Medicare and Medicaid Services' readmission reports inaccurately describe an institution's decompensated heart failure admissions.
    Cox ZL; Lai P; Lewis CM; Lenihan DJ
    Clin Cardiol; 2017 Sep; 40(9):620-625. PubMed ID: 28471510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will Hospital Peer Grouping by Patient Socioeconomic Status Fix the Medicare Hospital Readmission Reduction Program or Create New Problems?
    Fuller RL; Hughes JS; Goldfield NI; Averill RF
    Jt Comm J Qual Patient Saf; 2018 Apr; 44(4):177-185. PubMed ID: 29579442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commercial Negotiated Prices for CMS-specified Shoppable Radiology Services in U.S. Hospitals.
    Jiang JX; Makary MA; Bai G
    Radiology; 2022 Mar; 302(3):622-624. PubMed ID: 34846206
    [No Abstract]   [Full Text] [Related]  

  • 38. Health services utilization in the U.S. population by health insurance coverage.
    Garfinkel SA; Corder LS
    Natl Med Care Util Expend Surv B; 1986 Dec; (13):1-38. PubMed ID: 10304187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leveraging the big-data revolution: CMS is expanding capabilities to spur health system transformation.
    Brennan N; Oelschlaeger A; Cox C; Tavenner M
    Health Aff (Millwood); 2014 Jul; 33(7):1195-202. PubMed ID: 25006146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposal for a national coverage determination for the treatment of varicose veins and venous disease due to disparate Centers for Medicare and Medicaid Services local coverage determination policies.
    Welch HJ; Kabnick L; Vasquez MA; Monahan DL; Lurie F; Jacobowitz G
    J Vasc Surg Venous Lymphat Disord; 2017 May; 5(3):453-459. PubMed ID: 28411715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.